Significant resistance against influenza virus and Mycobacterium tuberculosis infections was induced when trehalose dimycolate from M. tuberculosis or M. bovis but not M. avium was combined with muramyl dipeptide. Trehalose dimycolate from M. tuberculosis, in contrast to that from M. avium, could confer resistance against Toxoplasma gondii infections.
Cells walls of adjuvant-active bacteria like mycobacteria, corynebacteria, and nocardia contain glycolipids which are composed of mycolic acid pairs esterified at the 6,6' positions of ot,ot-D-trehalose (2) . A peptidoglycan monomer, N-acetylmuramyl-L-alanyl-D-isoglutamine, also present on bacterial cell walls has been identified as the minimal structure essential for adjuvanticity (1) . Biological response modifiers like trehalose dimycolate (TDM) and muramyl dipeptide (MDP) possess many of the immunopotentiating properties of viable bacteria (1, 2) .
The combination of TDM with MDP in an oil-in-water emulsion possesses synergistic immunostimulatory activity and is highly effective against infections and tumors which do not respond to either compound alone. Significant protection against influenza virus infections could be induced by the combination of TDM with several 6-0-acyl, ubiquinone, aminobutyryl, and seryl derivatives of MDP (3) (4) (5) . Similarly, protection against aerogenic Mycobacterium tuberculosis infections was conferred only by the combination of TDM with MDP or analogs (5). Tumor-regressive effects against established line 10 hepatocarcinomas of strain 2 guinea pigs have also been obtained with emulsions of MDP derivatives plus TDM (7) . This has led to the practical veterinary application of mycobacterial cell wall skeleton plus TDM for the immunotherapy of equine sarcoids, equine melanomas, and bovine ocular carcinomas (12; T. M. Ribigen). Controlled clinical trials with the same combination in human patients with malignant melanomas and lung or gastric cancers have been reported or are in progress (14) . Several Table 1 . A high degree of resistance was consistently conferred by M. tuberculosis TDM (91% survival), followed by M. bovis TDM (77% survival), in contrast to the lower activity of M. avium TDM (28% survival). The effect on the multiplication of virulent M. tuberculosis of these TDM preparations combined with MDP was determined in the lungs of pretreated mice. The results of representative experiments (Table 2) show that M. tuberculosis TDM and M. bovis TDM could restrict the growth of virulent M. tuberculosis organisms (4-to 5-log difference versus the controls), in contrast to M. avium TDM, which did not exhibit a significant difference from the controls. Also, the effect of different TDM preparations on nonspecific resistance against the protozoan parasite Toxoplasma gondii was investigated. The challenge strain and dose were selected after pretitration to produce a mortality of around 70%. The results (Table 3) show the (11) . After trimethylsilylation, the thin-layer chromatograms of TDMs from M. tuberculosis Aoyama B and M. bovis AN5 revealed six components containing a-, ,B-, and -mnycolic acid, in contrast to TDM from M. avium D4, which contained fewer components and completely lacked ,B-mycolic acid (13) . In this connection it is of interest that in addition to (8) .
The oil-in-water emulsions of amphiphiles like TDM elicit a variety of biological effects which may be influenced by the surface properties of the oil-water interface. With hydrophobic beads coated with TDM, it has been shown that the length of the molecules at the interface is determined by the shorter a-branch of the mycolic acids (9) . Interestingly, the hydrocarbon chains of TDM from atypical M. smegmatis are shorter than those from M. tuberculosis, and avirulent mycobacteria contain less TDM than virulent bacilli (9) . Recent 
